Herpes zoster typically presents with pain described as burning or stabbing, followed by a vesicular rash in the affected dermatome; location of symptoms depends on the affected nerve.
Diagnosis is primarily based on the typical clinical symptoms, such as dermatomal pain and eruption of grouped vesicles in the same dermatome. Confirmation can be done using polymerase chain reaction (PCR) methods.
Treatment is primarily to reduce pain using analgesics and viral replication using antiviral medicine such as aciclovir.
Antiviral therapy may reduce the severity of postherpetic neuralgia. Early antiviral therapy is particularly important in ophthalmic zoster and zoster in the immunocompromised.
Herpes zoster (HZ), caused by reactivation of varicella-zoster virus (VZV) that was acquired during a primary varicella infection, is characterised by dermatomal pain and papular rash. The pain typically precedes the rash by several days and can persist for several months after the rash resolves. The rash usually presents in a single dermatome and typically resolves within 4 to 5 weeks. A common complication is postherpetic pain.
History and exam
Key diagnostic factors
- presence of risk factors
- localised pain in a dermatome
- corneal ulceration
Other diagnostic factors
- pain without rash
- >50 years of age
- female sex
- chronic corticosteroid use
- white ethnicity
1st investigations to order
- clinical diagnosis
Investigations to consider
- polymerase chain reaction (PCR)
- vesicular fluid culture
- HIV test
acute symptoms: immunocompetent
acute symptoms: immunocompromised
- Contact dermatitis
- Herpes simplex
- Recommended immunization schedule for adults aged 19 years or older: United States, 2022
- IAP guidebook on immunization 2018-19
Shingles: what is it?More Patient leaflets
- Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer